This is the guide

ABBOTT Laboratories actions fell on Thursday after the diversified medical care company delivered a second solid quarter, but left investors…

Goldman Sachs (GS) Gains Q2 2025

The Goldman Sachs CEO, David Solomon, speaks during the day of Goldman Sachs investors at the Goldman Sachs headquarters in…

The best selections of Biotechnology and Farma by JPMorgan for the second half

The low performance of biopharmaceutical actions versus the widest market for a third consecutive year is an opportunity for investors,…